Mond Harry G, Crozier Ian
Adjunct Associate Professor, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
Christchurch Hospital, Christchurch, New Zealand.
Heart Lung Circ. 2015 Mar;24(3):291-7. doi: 10.1016/j.hlc.2014.09.017. Epub 2014 Oct 5.
A pacemaker (PM) and implantable cardioverter-defibrillator (ICD) survey was undertaken in Australia and New Zealand for calendar year 2013.
For 2013, PMs sold as new implants in Australia was 15,203 (12,523 in 2009) and implanted in New Zealand were 1,641 (1,277 in 2009). The number of new PM implants per million population 652 for Australia (565 were in 2009) and 367 for New Zealand (299 in 2009). Although PM replacements rose in New Zealand, there was a fall in Australia as a result of improved power source service life. Pulse generator types sold in Australia were predominantly dual chamber 74% (71% in 2009) and implanted in New Zealand 59% (54% in 2009). There were 661 biventricular PMs implanted in Australia (446 in 2009) and 83 in New Zealand (45 in 2009). Transvenous pacing leads were overwhelmingly bipolar with preferences for active fixation leads, although, since 2009, there has been a minor resurgence in Australia of passive fixation lead usage in the atrium from 20 to ∼24%. There was also a marked increase in the ICD implants with 3904 new implants in Australia (3555 in 2009) and 423 in New Zealand (329 in 2009). The new ICD implants per million population were 167 for Australia (160 in 2009) and 95 for New Zealand (77 in 2009). Biventricular ICD implants increased significantly in both Australia (2211) and New Zealand (118).
2013年在澳大利亚和新西兰进行了一项起搏器（PM）和植入式心脏复律除颤器（ICD）调查。
2013年，澳大利亚作为新植入设备售出的起搏器为15,203台（2009年为12,523台），新西兰植入的为1,641台（2009年为1,277台）。澳大利亚每百万人口中新植入起搏器的数量为652台（2009年为565台），新西兰为367台（2009年为299台）。尽管新西兰的起搏器更换数量有所上升，但由于电源使用寿命的提高，澳大利亚的起搏器更换数量有所下降。在澳大利亚销售的脉冲发生器类型主要是双腔的，占74%（2009年为71%），在新西兰植入的占59%（2009年为54%）。澳大利亚植入了661台双心室起搏器（2009年为446台），新西兰植入了83台（2009年为45台）。经静脉起搏导线绝大多数是双极的，且更倾向于主动固定导线，不过自2009年以来，澳大利亚心房中被动固定导线的使用略有回升，从20%升至约24%。ICD植入数量也显著增加，澳大利亚有3904台新植入（2009年为3555台），新西兰有423台（2009年为329台）。澳大利亚每百万人口中新植入ICD的数量为167台（2009年为160台），新西兰为95台（2009年为77台）。澳大利亚（2211台）和新西兰（118台）的双心室ICD植入数量均显著增加。
